Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15

Author： Ballaré C.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.47, Iss.2, 1998-01, pp. : 163-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insights into the Role of Fc Gamma Receptors (Fc&ggr;Rs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 3, 2010-11 ,pp. : 197-204

Bentham Science Publishers

Access to resources Recommend Favorite

Silencing of glutaminase 1 resensitizes Taxol-resistant breast cancer cells to Taxol

By        

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4727-4773

Spandidos Publications

Access to resources Recommend Favorite

Pharmacodynamic study of 131I-labeled CA215 antibody on an animal model of estrogen-resistant OC-3-VGH ovarian cancer

By            

Experimental and Therapeutic Medicine, Vol. 10, Iss. 2, 2015-01 ,pp. : 572-578

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA-215 is upregulated by treatment with Adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissues

By Wang Li   Wang Yan Ming   Xu Song   Wang Wei Guo   Chen Yang   Mao Jing Yu   Tian Bo Le  

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-10 ,pp. : 5274-5280

Spandidos Publications

Access to resources Recommend Favorite

Liposomal 4-hydroxy-tamoxifen: effect on cellular uptake and resulting cytotoxicity in drug resistant breast cancer cells in vitro

By Zeisig Reinhard   Teppke Anne-Dorthee   Behrens Diana   Fichtner Iduna  

Breast Cancer Research and Treatment, Vol. 87, Iss. 3, 2004-10 ,pp. : 245-254

Springer Publishing Company

Access to resources Recommend Favorite